Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

205.30SEK
29 Jan 2015
Change (% chg)

-- (--)
Prev Close
205.30kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,041,588
52-wk High
236.90kr
52-wk Low
147.00kr

GETIb.ST

Chart for GETIb.ST

About

Getinge AB is a Sweden-based company active in the healthcare sector. It is engaged in the provision of products and services for intensive care units, care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas. The Medical... (more)

Overall

Beta: 0.56
Market Cap(Mil.): kr45,855.44
Shares Outstanding(Mil.): 222.38
Dividend: 2.80
Yield (%): 1.36

Financials

  GETIb.ST Industry Sector
P/E (TTM): 29.44 35.39 40.74
EPS (TTM): 7.00 -- --
ROI: 4.26 10.75 18.19
ROE: 10.50 12.58 19.08
Search Stocks

BRIEF-Getinge CFO says acquisition capacity around 6-7 bln SEK

* Acquisition capacity around 6-7 bln SEK Further company coverage: (Reporting By Sven Nordenstam)

28 Jan 2015

UPDATE 1-Getinge shares shoot up as U.S. regulatory woes clear

* Q4 adjusted EBITA 1.99 bln SEK vs poll forecast 2.11 bln. (Adds detail, background, shares)

28 Jan 2015

Getinge sees end of FDA woes as Q4 profit lags forecast

STOCKHOLM, Jan 28 - Swedish medical technology firm Getinge said on Wednesday it expected to reach a deal soon with the U.S. Food and Drug Administration over quality management, costing it about 500 million Swedish crowns ($61 million) in 2015 as it posted fourth-quarter core profit below expectations.

28 Jan 2015

Getinge sees end of FDA woes as Q4 profit lags forecast

STOCKHOLM, Jan 28 - Swedish medical technology firm Getinge said on Wednesday it expected to reach a deal soon with the U.S. Food and Drug Administration over quality management, costing it about 500 million Swedish crowns ($61 million) in 2015 as it posted fourth-quarter core profit below expectations.

28 Jan 2015

Getinge CEO says resignation unrelated to any FDA developments

STOCKHOLM, Jan 12 - Outgoing Getinge Chief Executive Johan Malmquist said on Monday that his decision to step down had nothing to with any new developments in ongoing discussions with the U.S. Food and Drug Administration (FDA) over quality controls.

12 Jan 2015

Alex Myers appointed new CEO of Sweden's Getinge

Jan 12 - Medical technology group Getinge said on Monday that Alex Myers would take over as Chief Executive of the company, after Johan Malmquist had decided to resign after 18 years as its chief.

12 Jan 2015

European shares hit 13-month low on growth, deflation worries

LONDON/PARIS, Oct 16 - European shares extended steep losses on Thursday on mounting concerns over weakness in the global economy and fears of deflation in the euro zone, sending a benchmark index to a 13-month low at one point.

16 Oct 2014

European shares hit 13-month low on growth, deflation worries

LONDON/PARIS, Oct 16 - European shares extended their recent steep losses on Thursday, with a benchmark index slipping to a 13-month low, on mounting concerns over weakness in the global economy and fears of deflation in the euro zone.

16 Oct 2014

BRIEF-Getinge CEO says 2014 earnings will not be far from consensus

STOCKHOLM, Oct 16 - Getinge CEO at earnings call:

16 Oct 2014

BRIEF-Getinge CEO: Revenues from products in scope of FDA dialogue 3-3.5 bln SEK

STOCKHOLM, Oct 16 - Getinge Ab CEO at earnings call:

16 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$10.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks